US 9085599
2′allene-substituted nucleoside derivatives
granted A61KA61K31/7056A61K31/706
Quick answer
US patent 9085599 (2′allene-substituted nucleoside derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7056, A61K31/706, A61K31/7068, A61K31/7072